PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.83%
Some net income increase while MCHP is negative at -50.82%. John Neff would see a short-term edge over the struggling competitor.
2.43%
D&A growth well above MCHP's 0.38%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
1300.00%
Some yoy growth while MCHP is negative at -2776.92%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-27.54%
Negative yoy SBC while MCHP is 3.02%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
336.76%
Well above MCHP's 142.99% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-785.71%
AR is negative yoy while MCHP is 205.32%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-132.50%
Both reduce yoy inventory, with MCHP at -11.43%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
305.88%
AP growth well above MCHP's 243.33%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
339.29%
Some yoy usage while MCHP is negative at -77.83%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
108.77%
Well above MCHP's 138.07%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
14.47%
Operating cash flow growth 1.25-1.5x MCHP's 11.83%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
-25.91%
Both yoy lines negative, with MCHP at -239.68%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
25.91%
Acquisition growth of 25.91% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
13.27%
Purchases growth of 13.27% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-46.44%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-34.57%
Both yoy lines negative, with MCHP at -23.50%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-796.06%
Both yoy lines negative, with MCHP at -23.50%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
38.89%
We slightly raise equity while MCHP is negative at -43.01%. John Neff sees competitor possibly preserving share count or buying back shares.
4.79%
Buyback growth of 4.79% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.